Advertisement

KORU Medical Systems, Inc. KRMD

Set alert

Price alert · KRMD

All alert types
2.99 USD -0.24 -7.43%

At close · Oct 30

3.02 +0.03 +1.00%

After hours · Oct 30, 4:00 PM ET

Bid
2.99 × 2
Ask
3.00 × 2
2.99 Day range 3.25
2.93 52-week range 6.52
YTD
-48.54%
1 year
-23.33%
Open
3.24
Prev close
3.23
Mkt cap
138.05M
Vol
165.22K
Avg vol
241.15K
EPS
-0.04
P/E
0.00
Div yield
0.00%
More statistics
Low
2.99
High
3.25
Forward P/E
-43.89
Beta
0.41
Short ratio
11.67
Inst. own
54.38%
Dividend
0.00
Ex-div date
50-d avg
3.27
200-d avg
2.59
1y target
4.90

1D chart

Chart tools
Interval

Signals (10)
NameTimeAgo
MACD: Sell Signal4:00 PM2 days ago
MACD: Buy Signal3:49 PM2 days ago
MACD: Sell Signal3:48 PM2 days ago
RSI: Oversold3:45 PM2 days ago
MACD: Buy Signal2:49 PM2 days ago
RSI: Oversold2:42 PM2 days ago
MACD: Sell Signal2:11 PM2 days ago
RSI: Oversold2:11 PM2 days ago
MACD: Buy Signal1:49 PM2 days ago
MACD: Sell Signal1:13 PM2 days ago

Key statistics

Market cap
181.06M
Enterprise value
134.74M
Trailing P/E
0.00
Forward P/E
-43.89
PEG ratio
0.00
Price / sales
5.88
Price / book
8.86
EPS (TTM)
-0.26
Beta
0.41
Dividend yield
0.00%
Payout ratio
0.00%
Profit margin
-38.16%
Revenue (TTM)
30.82M
Revenue growth
21.50%
Free cash flow
1.05M
Total cash
10.46M
Total debt
3.97M
Return on equity
-50.25%
Shares outstanding
45.84M
Short % of float
2.06%
50-day average
3.27
200-day average
2.59

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 4.90 +63.9% upside
Target (low)
3.50
Target (mean)
4.90
Target (high)
7.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy4
  • Hold0
  • Sell0
  • Strong sell0

Next earnings

Consensus EPS estimate -0.0325.

Earnings history

Financials — quick view

All financials
KRMD Revenue — quarterly 12.05M
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
KRMD Net income — quarterly 252.45K
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026
KRMD EPS — quarterly 0.01
2022-Q3 20222022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 2026

Earnings

KRMD recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Nov 13, 2024Sep 1, 2024-0.03-0.030.000.00%
Aug 7, 2024Jun 1, 2024-0.04-0.02+0.02+50.00%
May 1, 2024Mar 1, 2024-0.04-0.02+0.02+50.00%
Mar 13, 2024Dec 1, 2023-0.04-0.02+0.02+50.00%
Nov 8, 2023Sep 1, 2023-0.04-0.03+0.01+25.00%
Aug 9, 2023Jun 1, 2023-0.05-0.050.000.00%

Upgrades / downgrades

KRMD analyst upgrades and downgrades
DateFirmActionFromTo
Nov 14, 2024Craig-HallummainBuyBuy
Nov 14, 2024Canaccord GenuitymainBuyBuy
Nov 14, 2024Piper SandlermainOverweightOverweight
Aug 8, 2024Piper SandlermainOverweightOverweight
Mar 14, 2024B. Riley SecuritiesreitBuyBuy
Dec 7, 2023Canaccord GenuityreitBuyBuy

About KORU Medical Systems, Inc.

KORU Medical Systems, Inc. develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria. Its products include the FREEDOM60 syringe infusion system, the FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was incorporated in 1980 and is based in Mahwah, New Jersey.

Sector
Healthcare
Industry
Medical Instruments & Supplies
Country
United States

News

Your note

Sign in to keep a note on KRMD — it syncs with the Stock Master app.

Insider holders

KRMD insider holders
InsiderRelationLatest transactionDateShares held
BECK JAMES M.DirectorStock Award(Grant)Jun 29, 202390,284
CASCELLA ROBERT ADirectorStock Award(Grant)Sep 30, 202470,978
FLETCHER R JOHNChairman of the BoardStock Award(Grant)Sep 30, 2024190,851
FRENCH DONNADirectorStock Award(Grant)Sep 30, 202470,978
MANKO JOSEPH M JRDirector and Beneficial Owner of more than 10% of a Class of SecurityStock Award(Grant)Sep 29, 20240
MATIN SHAHRIARDirectorStock Award(Grant)Sep 30, 202473,608

Institution ownership

KRMD institution ownership
Holder% heldSharesValueReported
First Light Asset Management, LLC14.04%5,598,92522.12MSep 29, 2024
Vanguard Group Inc4.47%1,782,8017.04MSep 29, 2024
Meros Investment Management, Lp2.02%805,3843.18MSep 29, 2024
Albion Financial Group1.67%667,7832.64MSep 29, 2024
RBF Capital, LLC1.31%521,3192.06MSep 29, 2024
Geode Capital Management, LLC1.16%462,1281.83MSep 29, 2024

Fund ownership

KRMD fund ownership
Holder% heldSharesValueReported
Vanguard Total Stock Market Index Fund2.86%1,140,6514.51MSep 29, 2024
Vanguard Extended Market Index Fund1.45%579,5412.29MSep 29, 2024
Fidelity Extended Market Index Fund0.62%245,888971.26KOct 30, 2024
iShares Micro Cap ETF0.21%85,301336.94KOct 30, 2024
Fidelity Total Market Index Fund0.18%73,136288.89KOct 30, 2024
Forum Funds II-Acuitas U.S. Micro Cap Fund0.17%68,232269.52KSep 29, 2024
Advertisement